Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02370914 · ClinicalTrials.gov registry record
Concussion Testing: A Novel Non-invasive Concussion Detection Device
A clinical trial, sponsored by Jan Medical.
- Completed
- Registry status
- 84
- Enrollment target
NCT02370914: Completed study, sponsored by Jan Medical.
NCT02370914 is a clinical trial that has completed, run by Jan Medical. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02370914 has completed, sponsored by Jan Medical.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to establish and evaluate a distinctive signal for concussion.
Primary Outcome
Sensitivity (also called the true positive rate) measures the proportion of concussed participants that are correctly identified as such by utilizing the information within the Nautilus Neurowave data. Specificity (also called the true negative rate) measures the proportion of non-concussed participants that are correctly identified as such by utilizing the information within the Nautilus Neurowave data The information that is evaluated from within this data is recognized through the computatio
Interventions
- DEVICE Nautilus NeuroWaveTM System
- BEHAVIORAL SCAT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-12 |
What the finished NCT02370914 record still lists
NCT02370914 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Nautilus NeuroWaveTM System is the first listed.
NCT02370914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02370914 about?
NCT02370914 is a clinical study titled "Concussion Testing: A Novel Non-invasive Concussion Detection Device". The purpose of this study is to establish and evaluate a distinctive signal for concussion.
What is the current status of trial NCT02370914?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2011-08. Estimated completion is 2011-12.
What interventions are being tested in trial NCT02370914?
The interventions under investigation include: Nautilus NeuroWaveTM System (DEVICE), SCAT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02370914?
This trial is sponsored by Jan Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia